This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Mar 1;141(3):283-284.

doi: 10.1001/jamaophthalmol.2022.6436.

Perspectives on Evolving Gene Therapy for X-Linked Retinitis Pigmentosa

Sabyasachi Sengupta¹

Affiliations

PMID: 36757711
DOI: 10.1001/jamaophthalmol.2022.6436

Comment

Perspectives on Evolving Gene Therapy for X-Linked Retinitis Pigmentosa

Sabyasachi Sengupta. JAMA Ophthalmol. 2023.

. 2023 Mar 1;141(3):283-284.

doi: 10.1001/jamaophthalmol.2022.6436.

Author

Sabyasachi Sengupta¹

Affiliation

¹ Future Vision Eye Care and Research Centre, Mumbai, India.

PMID: 36757711
DOI: 10.1001/jamaophthalmol.2022.6436

No abstract available

PubMed Disclaimer

Comment on

Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
von Krusenstiern L, Liu J, Liao E, Gow JA, Chen G, Ong T, Lotery AJ, Jalil A, Lam BL, MacLaren RE; XIRIUS Part 1 Study GroupXOLARIS Study Group. von Krusenstiern L, et al. JAMA Ophthalmol. 2023 Mar 1;141(3):275-283. doi: 10.1001/jamaophthalmol.2022.6254. JAMA Ophthalmol. 2023. PMID: 36757689 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems